Orion Health Finalizes Investment Deal with Hg Rhapsody acquisition completed, Population Health investment secured TORONTO, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Orion Health (NZX:OHE/ASX:OHE) today announced the completion of its transaction with technology investor Hg for the acquisition of Rhapsody and a 24.9% stake in Orion Health’s Population Health Management business. Orion Health retains a 24.9% investment in the Rhapsody business and remains a majority owner of its Population Health business at 75.1%. This is a significant milestone for Orion Health, signalling the next chapter fo...
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind...
Orion Health Group (OHE) is a dual-listed technology leader offering an end to end population health management solution (software and consulting services) and targeting those who both fund and provide healthcare services: private and public hospitals, healthcare provider networks, insurers, health information exchanges, research bodies and pharmaceutical companies. The company listed in November 2014, raising NZ$125m to support additional research and development and assist in its transition to...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.